Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A PHASE I TRIAL OF BTK INHIBITOR PCI-32765 IN PATIENTS WITH RELAPSED NON-HODGKIN'S LYMPHOMA: EVIDENCE OF ANTITUMOR ACTIVITY Fowler, N., Sharman, J., Smith, S., Pollyea, D., Boyd, T., Grant, B., Kathryn, K., Buggy, J., Loury, D., Hamdy, A., Advani, R. FERRATA STORTI FOUNDATION. 2010: 371
View details for Web of Science ID 000496828403188